Progression-Free Survival and Treatment-Free Interval in Head and Neck Cancer with Long-Term Response to Nivolumab: Timing of Active Discontinuation

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancers

Topics

Medicine

Cancer Oncology

Internal Medicine

Surgery

Pulmonary And Respiratory Medicine

Show all topics

DOI

10.3390/cancers16142527

License

CC-BY

Other Formats

PDF